key: cord-0914316-boqfjphy
authors: Feuchtner, Gudrun M.; Barbieri, Fabian; Luger, Anna; Skalla, Elisabeth; Kountchev, Jordan; Widmann, Gerlig; Plank, Fabian
title: Myocardial injury in COVID-19: The role of coronary computed tomography angiography (CTA)
date: 2020-07-17
journal: J Cardiovasc Comput Tomogr
DOI: 10.1016/j.jcct.2020.07.002
sha: 3be222fdb861e8c35a19931446feebf591910c28
doc_id: 914316
cord_uid: boqfjphy

nan

A 48-year-old-female was diagnosed with SARS-CoV-2 infection by reverse-transcriptasepolymerase-chain-reaction. One day later, she experienced an episode of acute typical chest pain and was transferred to our hospital due to elevated cardiac enzymes (high-sensitivity Troponin-T: 542,6 ng/l (reference upper level (RUL): 14 ng/l) and creatine kinase (CK): 226 U/l (RUL: 170 U/l).

Electrocardiogram showed intermittent negative T-waves in inferior leads (II, III, aVF, V4 and V5) matching with inferior wall motion abnormalities in transthoracic echocardiography, leading to the diagnosis of non ST-elevation myocardial infarction (NSTEMI). C-reactive protein, interleukin-6, neopterin, procalcitonin and blood count were normal.

Coronary ECG-gated computed tomography angiography (CTA) ruled out coronary stenosis >50% but showed midventricular systolic constriction (Movie 1) without apical ballooning. Subendocardial myocardial perfusion defects were found in multiple myocardial segments ( Fig.1) representing typical imaging findings for myocardial infarction with non-obstructive coronary arteries (MINOCA). Cardiac magnetic resonance imaging (CMR) confirmed subendocardial inferior zonal late enhancement.

Coronary CTA (Fig.2 ) further showed diffuse irregular vessel walls thickening and perivascular edema, defined as a perivascular fat attenuation index (FAI) of >-70HU, suggestive for vasculitis. There was no typical COVID-19 pulmonary involvement. The patient was treated with acetylsalicylic acid and clopidogrel. Cardiac enzymes declined after 2 days and she was discharged asymptomatic after 6 days.

Myocardial damage during SARS-CoV-2 infection occurs in 8-12% (1) and more commonly, during severe clinical courses. In our patient, symptoms were mild and CTA-images showed midventricular systolic constriction but without apical ballooning. Multiple zonal subendocardial myocardial perfusion defects were present but no coronary stenosis > 50%, suggesting MINOCA, which was confirmed by CMR late-enhancement. CMR ruled out myocarditis. Invasive coronary angiography was avoided. Further, CTA showed signs of vasculitis with diffuse wall irregularities and focal thickening, which may trigger endothelial dysfunction and vasospasm. Perivascular edema was quantified by coronary CTA using the fat-attenuation-index (FAI), which was >-70 HU and as well supports the presence of perivascular inflammation. SARS-CoV-2 may infect the endothelium over ACE-2 receptors. Viral elements within endothelial cells and inflammatory cell death were recently confirmed on pathohistology (2). In addition, SARS-CoV-2 has been linked with procoagulative states and hence may favor microvascular thrombosis, which represents a further possible cause of MINOCA.

In summary, coronary CTA was a useful imaging modality in our patient with NSTEMI and SARS-CoV-2 infection to avoid invasive angiography. CTA imaging findings should be regarded as "hypothesisgenerating" for the initiation of further systematic research studies. 

Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis

Endothelial cell infection and endotheliitis in COVID-19

Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data

The authors declare no conflict of interest. The manuscript has not been submitted elsewhere.